The DOI matches its Crossref record; 315 of the 318 references it cites were found in a registry or an index.
The challenges of primary biliary cholangitis: What is new and what needs to be done
Open accessAbstract
Primary Biliary Cholangitis (PBC) is an uncommon, chronic, cholangiopathy of autoimmune origin and unknown etiology characterized by positive anti-mitochondrial autoantibodies (AMA), female preponderance and progression to cirrhosis if left untreated. The diagnosis is based on AMA- or PBC-specific anti-nuclear antibody (ANA)-positivity in the presence of a cholestatic biochemical profile, histologic confirmation being mandatory only in seronegative cases. First-line treatment is ursodeoxycholic acid (UDCA), which is effective in preventing disease progression in about two thirds of the patients. The only approved second-line treatment is obeticholic acid. This article summarizes the most relevant conclusions of a meeting held in Lugano, Switzerland, from September 23rd-25th 2018, gathering basic and clinical scientists with various background from around the world to discuss the latest advances in PBC research. The meeting was dedicated to Ian Mackay, pioneer in the field of autoimmune liver diseases. The role of liver histology needs to be reconsidered: liver pathology consistent with PBC in AMA-positive individuals without biochemical cholestasis is increasingly reported, raising the question as to whether biochemical cholestasis is a reliable disease marker for both clinical practice and trials. The urgent need for new biomarkers, including more accurate markers of cholestasis, was also widely discussed during the meeting. Moreover, new insights in interactions of bile acids with biliary epithelia in PBC provide solid evidence of a role for impaired epithelial protection against potentially toxic hydrophobic bile acids, raising the fundamental question as to whether this bile acid-induced epithelial damage is the cause or the consequence of the autoimmune attack to the biliary epithelium. Strategies are needed to identify difficult-to-treat patients at an early disease stage, when new therapeutic approaches targeting immunologic pathways, in addition to bile acid-based therapies, may be effective. In conclusion, using interdisciplinary approaches, groundbreaking advances can be expected before long in respect to our understanding of the etiopathogenesis of PBC, with the ultimate aim of improving its treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245
An Expanded View of Complex Traits: From Polygenic to Omnigenic
Boyle, E. A., Li, Y. I., & Pritchard, J. K. (2017) · Cell · doi:10.1016/j.cell.2017.05.038 · Cited by 2,851
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., et al. (2008) · Science · doi:10.1126/science.1164206 · Cited by 2,081
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,016
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y. S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Björck, I., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.001 · Cited by 1,731
Flagged first, then by citations
3 of the 318 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Addison, 1851, On a certain affection of the skin, Vitiligoidea:(a) Plana,(b) Tuberosa, Guy’s Hosp. Rep., 7, 267
- Hohenester, 2012, A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes, Hepatology, 55, 173, 10.1002/hep.24691 · DOI · Paper page
- Rojas, 2018, Molecular mimicry and autoimmunity, J. Autoimmun., 95, 100, 10.1016/j.jaut.2018.10.012 · DOI · Paper page
Cited by
Sorted by citations
Items 101–113 of 113
Geschlechtsspezifische Unterschiede in gastroenterologischen Erkrankungen
Roth, L., Michl, P., & Rosendahl, J. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01491-4
Inflammatory Hepatobiliary Diseases
Beretta‐Piccoli, B. T., Selmi, C. F., Manns, M. P., & Gershwin, M. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00076-9
Self-citationLan, T., Li, S., Yu, H., Kostallari, E., & Gao, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305666
Biagi, M., Bernasconi, E., Cursaro, C., Ronconi, E., Zanni, F., Sighinolfi, P., & Andreoné, P. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00033
Metabolomics-based Investigation of Primary Biliary Cholangitis: A Cholestatic Liver DiseasePreprint
de Oliveira, J. M., Lopes, T. D. A., Castro, A., Signini, É. D. F., Catai, A. M., Ferreira, A. G., Cançado, E. L. R., & Oliveira, R. V. (2024) · Research Square · doi:10.21203/rs.3.rs-3898120/v1
Reply to: “ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort”
Tang, R., Li, Y., Chen, R., & Ma, X. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.016
Self-citation邹, 沛. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153801
Atypical acquired hemophilia linked with primary biliary cholangitis: a unique case presentation
Megdiche, F., Siala, N., Kallel, F., Krichen, I., Hachicha, H., Frikha, I., Charfi, M., Kallel, N., Medhaffar, M., Masmoudi, H., et al. (2025) · Future Science OA · doi:10.1080/20565623.2025.2489329
“Most of the patients are women and the median age of discovery of the disease is about 60 years old [12]. pBC could be frequently associated to other autoimmune pathologies as well as autoimmune hepatitis [14].”
Qasim, B., Kumari, H., Kashif, S. N., Abbas, S. M. I., Hani, O., Salma, O., Sauleh, A., Adnan, F., Ali, M., Raheem, A., et al. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00464-6
Zhang, M., Wang, C., Huang, Y., Wang, L., Dai, Y., Jiang, Y., Han, C., Gong, Y., Li, L., Tian, Y., et al. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09102-w · Cited by 1
“Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by the destruction of intrahepatic small bile ducts and progressive cholestasis, ultimately leading to liver cirrhosis and hepatic failure [1, 2].”
Self-citationCheckpoint inhibitor-induced cholangiopathy
Atallah, E., Kotha, S., Berry, P., Zen, Y., Cratchley, A. L., Joshi, D., & Chimakurthi, C. R. (2025) · Frontline Gastroenterology · doi:10.1136/flgastro-2024-103050
Primary Biliary Cholangitis—The Changing Biomarker Paradigms for Staging Fibrosis
Moyana, T. N. (2026) · Livers · doi:10.3390/livers6020023
Autoimmune Biliary Diseases: From Fragmented Pathways to Precision Diagnosis
Bedran, A., Hoyek, K., Houcheimy, D. A., Kreidi, J., Chami, A., Nabhan, S., Karam, K., & Bedran, K. (2026) · Sage Open Pathology · doi:10.1177/30502098261472445
Metadata
- Authors
- Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., Carbone, M., Chazouillères, O., Dalekos, G., De Gottardi, A., Harada, K., Hirschfield, G., Invernizzi, P., Jones, D., Krawitt, E., Lanzavecchia, A., Lian, Z.-X., Ma, X., Manns, M., Mavilio, D., Quigley, E. M., Sallusto, F., Shimoda, S., Strazzabosco, M., Swain, M., Tanaka, A., Trauner, M., Tsuneyama, K., Zigmond, E., & Gershwin, M. E.
- Affiliations
- King's College Hospital (GB)
- Baylor College of Medicine (US)
- NIHR Birmingham Biomedical Research Centre (GB)
- Richard L. Roudebush VA Medical Center (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- University of California, Davis (US)
- University of Milan (IT)
- Hôpital Saint-Antoine (FR)
- University of Thessaly (GR)
- Kanazawa University (JP)
- University Health Network (CA)
- NIHR Newcastle Biomedical Research Centre (GB)
- University of Vermont (US)
- Institute for Research in Biomedicine (CH)
- South China University of Technology (CN)
- Shanghai Jiao Tong University (CN)
- Medizinische Hochschule Hannover (DE)
- Houston Methodist (US)
- Kyushu University (JP)
- Yale University (US)
- University of Calgary (CA)
- Teikyo University (JP)
- Medical University of Vienna (AT)
- Tokushima University (JP)
- Tel Aviv University (IL)
- ORCID
- Vergani, Diego
- Vierling, John M.
- Adams, David
- Alpini, Gianfranco
- Beuers, Ulrich
- Bowlus, Christopher
- Carbone, Marco
- Chazouillères, Olivier
- Dalekos, George
- Harada, Kenichi
- Hirschfield, Gideon
- Invernizzi, Pietro
- Jones, David
- Lanzavecchia, Antonio
- Lian, Zhe-Xiong
- Ma, Xiong
- Manns, Michael
- Mavilio, Domenico
- Sallusto, Federica
- Shimoda, Shinji
- Strazzabosco, Mario
- Swain, Mark
- Tanaka, Atsushi
- Trauner, Michael
- Tsuneyama, Koichi
- Zigmond, Ehud
- Gershwin, M. Eric
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 105
- Pages
- 102328
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W2974241762
- Cited by
- 114
- References
- 318
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 13 · 2023: 18 · 2022: 26 · 2021: 21 · 2020: 18 · 2019: 3
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- Journal of Autoimmunity (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NIHR200243, NF-SI-0513-10091)
- Medical Research Council (MR/L001489/1)
- Japan Society for the Promotion of Science (18K07069, 17H04058)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- primary biliary cirrhosis, antimitochondrial antibodies, antinuclear antibodies, ursodeoxycholic acid, obeticholic acid, liver histopathology, bile acids, biliary epithelium, autoimmune liver disease, disease progression, difficult-to-treat patients, etiopathogenesis
- MeSH terms
- Antibodies, Antinuclear, Autoimmune Diseases, Chenodeoxycholic Acid, Cholagogues and Choleretics, Congresses as Topic, Female, Humans, Liver, Liver Cirrhosis, Biliary, Ursodeoxycholic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
